Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance.

The New England journal of medicine - 23 Sept 2021

Bose Ron, Ma Cynthia X

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Breast Neoplasms
Share to Drug Resistance, Neoplasm
Share to Protein Kinase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Quinolines

Share to Receptor, ErbB-2

Share to Receptor, ErbB-3

Share to Signal Transduction

Source

Identifiers

PMID: 34551235
DOI: 10.1056/NEJMcibr2110552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance.PMID 34551235Read ↗

The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistanceSemantic proximity Read ↗

New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistanceSemantic proximity Read ↗

Molecular aspects of breast cancer resistance to drugs (Review).Semantic proximity Read ↗

Resistance to Anti-HER2 Therapies in Breast CancerSemantic proximity Read ↗

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistanceSemantic proximity Read ↗

New agents for endocrine resistance in breast cancer.Semantic proximity Read ↗

Analysis of different HER-2 mutations in breast cancer progression and drug resistance.Semantic proximity Read ↗

Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity Read ↗

Targeted therapies for breast cancer.Semantic proximity Read ↗

Genetic Influences in Breast Cancer Drug ResistanceSemantic proximity Read ↗

Herceptin resistance database for understanding mechanism of resistance in breast cancer patients.Semantic proximity Read ↗

HER2-family signalling mechanisms, clinical implications and targeting in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.